Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
Francisco J. Esteva, Carol D. Cheli, Herbert Fritsche, Monica Fornier, Dennis Slamon, Robert P. Thiel, Diana Luftner, Farooq Ghani
Research output: Contribution to journal › Article › peer-review
139Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.'. Together they form a unique fingerprint.